Ibarani, Jenilyn .
HRN: 16-50-64 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFUROXIME 750MG (VIAL)
12/27/2025
12/28/2025
IV
750 Mg
Every 8 Hours
S/P NSVD With Inc Wbc
Checking Initial Appropriateness
12/27/2025
CEFUROXIME 500MG (TAB)
12/27/2025
01/02/2026
PO
500 Mg
BID
S/P NSVD With Inc Wbc
Checking Initial Appropriateness